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Fostriecin is a unique phosphate monoester antibi-
otic that was isolated from Streptomyces pulvera-
ceus as a protein phosphatase 2A (PP2A) and PP4A
selective inhibitor. However, its biosynthetic mecha-
nism remains to be elucidated. In this study, a 73 kb
genecluster encodingasixmodular Type I polyketide
synthases (PKS) and seven tailoring enzymes was
identified by cosmid sequencing from the producer.
The functions of two tailoring enzymes were charac-
terized by gene disruption and an in vitro enzyme
activity assay. Remarkably, the isolation of three
malonylated fostriecin analogs from post-PKS gene
knockout mutants indicated malonylated-polyketide
formation could be a normal biosynthetic process
in the formation of the unsaturated six-membered
lactone in fostriecin. Based on this study, a com-
prehensive post-PKS modification mechanism for
fostriecin biosynthesis was proposed.
INTRODUCTION
Fostriecin (CI-920, PD110,161), PD113,270, and PD113,271
were originally isolated from a fermentation culture of Strepto-
myces pulveraceus and are a class of phosphate ester natural
products that are structurally related to cytostatin and phoslac-
tomycin (Figure 1) (Amemiya et al., 1994; Hokanson and French,
1985; Hu et al., 2005; Kohama et al., 1993). Studies suggest that
fostriecin is a phosphatase inhibitor with a 104-fold specificity for
PP2A/PP4 over PP1, enzymes that play an important role in
signal transduction, cell growth, and cell division (Lewy et al.,
2002; Walsh et al., 1997). Therefore, fostriecin has attracted
intense interest as a lead compound and was under evaluation
as an antitumor drug in clinical trials. Although phase I clinical
trials of fostriecin were halted due to its unpredictable chemical
purity and storage instability, the comprehensive chemical
synthesis of fostriecin and its analogs is under development to
address these limitations and to further develop this specific
antitumor agent (Lewy et al., 2002).
Polyketides represent a major class of antibiotics that are
generated on multimodular enzymatic assembly lines. The
modularity of the scaffold biosynthesis, together with theChemistry & Biology 20,plurality of post-assembly modifications by tailoring enzymes,
offers the prospect of creating various antibiotics with optimized
activity, production, and pharmacokinetics. Phoslactomycins,
antibiotics that are structurally related to fostriecin, were isolated
from Streptomyces sp. HK803, and their biosynthesis mecha-
nism was investigated (Palaniappan et al., 2003). However, the
biosynthetic mechanism of fostriecin remains to be elucidated.
The principle differences between phoslactomycin and fostriecin
are the replacement of the C-8 methyl group by ethylamine, by
methyl group at C-4 and the substitution of the terminal allelic
alcohol by a cyclohexane ring in the phoslactomycin structure.
Importantly, phoslactomycins are potent and highly selective
inhibitors of PP2A (IC50 values ranging from 3.7–5.8 uM)
compared to PP1 (IC50 > 1 mM). Recently, the PP2A inhibitory
activity of phoslactomycin has been shown to inhibit tumor
metastasis through the augmentation of natural killer cells. The
unique and selective biological activity of this class of natural
products has attracted considerable interest in recent years.
Although some analogs of fostriecin have been synthesized,
providing useful structure-activity relationship data, the com-
plexity of these molecules precludes the synthesis of many
potentially desirable analogs. The details of the biosynthesis
mechanism of fostriecin and phoslactomycin are being pursued
to overcome the limitations of their chemical activity and
to further develop this class of specific antitumor agents. The
gene cluster for phoslactomycin has been cloned and character-
ized, but the hypothetical scheme for its complex biosynthesis
events remains in need of further elucidation (Palaniappan
et al., 2003). Here, we have cloned and characterized the fostrie-
cin biosynthetic gene cluster and assigned putative biosynthetic
roles for the encoded enzymes. Using comparative analysis of
the gene cluster, in vitro enzyme activity assays and character-
ization of compounds produced by gene knockouts, we have
proposed a plausible scheme for fostriecin biosynthesis. Our
study, combined with the previous phoslactomycin reports,
enables the rapid exploitation of these molecules and provides
a framework for further studies of these complex pathways.
RESULTS
Isolation and Characterization of the Fostriecin
Biosynthesis Gene Cluster from Streptomyces
pulveraceus
There are numerous approaches for the identification and
isolation of polyketide synthase (PKS) gene clusters from45–54, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 45
Figure 1. Chemical Structures of Fostriecin
and Its Related Compounds
These structurally related compounds share the
same feature, a six-membered lactone with a
cis-D2,3-double bond.
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Fostriecin Biosynthesis Mechanismvarious organisms. A simple method has been developed for
the identification and isolation of modular (Type I) PKS genes
from various organisms that involves sequencing the ends of
cosmid inserts of a random genomic DNA library containing
one or more modular PKS gene clusters. The PKS fragment
identified from the sequencing effort can then be used as ‘‘a
perfect probe’’ to isolate all of the modular PKS clusters in an
organism (Hu et al., 2005; Santi et al., 2000). A modification
of this method that allowed the rapid and facile cloning and
identification of an interesting modular PKS gene cluster was
developed in this study for the cloning of the entire fostriecin
gene cluster.46 Chemistry & Biology 20, 45–54, January 24, 2013 ª2013 Elsevier Ltd All rights reservedA cosmid library from the
S. pulveraceus ATCC 31906 genome
was constructed on Supercos-1 (Strata-
gene, La Jolla, CA), and the end
sequences from the inserts of 1,000
cosmids were obtained and used for
BLAST analysis. There were 28 cosmids
containing Type I or Type II PKS
sequences at either end or both ends.
Restriction analysis of those sequences
revealed that there were two PKS
clusters. The cosmid Cfos-F2 from one
PKS group that contained a unique
P450 sequence at one end and a Type I
PKS at the other end was selected to
sequence first. The sequencing of Cfos-
F2 revealed four complete PKS modules
with one partial module, one P450 gene,
and one homoserine kinase gene, which
was consistent with the hypothetical
biosynthesis of fostriecin. Three other
overlapping cosmids, Cfos-F1, Cfos-F3,
and Cfos-F4, which are in the same group
as Cfos-F2, were individually and com-
pletely sequenced using a shotgun
cloning strategy. A total of 73 kb of con-
tiguous DNA was cloned and sequenced
to provide the complete DNA sequence
for the fostriecin gene cluster (Figure 2).
The sequence was deposited in the
GenBank database under the accession
number HQ434551.
Organization of the Fostriecin
Biosynthetic Gene Cluster
The DNA fragment that spans 73 kb
from four cosmids (Cfos-F1–F4) and
contains all of the putative biosynthetic
genes that are required for fostriecinbiosynthesis is shown to contain 21 open reading frames
(ORFs). The deduced gene organization within this region is
shown in Figure 2. The presumed functions of the open reading
frames for post-PKS in the fostriecin biosynthetic gene cluster
is listed in Table 1.
The organization of the fostriecin modules encoding the
multifunctional PKS is more complex than the known polyketi-
des, such as tautomycetin, leptomycin, and erythromycin
(Hu, et al., 2005; Li, et al., 2009), in which the PKS modules
are tfcgenerally found squeezed into their genomes. The PKS
modules in the fostriecin gene cluster are concentrated at two
positions, with six additional ORFs that may encode post-PKS
Figure 2. Distribution of Sequenced Cos-
mids and Organization of the Fostriecin
Biosynthetic Gene Cluster
The sequenced 73 kb DNA region from
S. pulveraceus ATCC 31906 as represented by the
four overlapping cosmids Cfos-F1-F4. The PKS
modules for the fostriecin locus at two positions,
with six additional tailoring enzymes centralized in
the PKS. The orientation of the arrows indicates
the direction of transcription.
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mycin gene cluster.
Speculation as to the domain functions was based on the
sequence homology to known PKS domains. As shown in Fig-
ure 3, a total of six large ORFs encode the core Fos-PKS, which
contains a total of nine modules, including FosA, which has
a loading module, and FosF, which has a thioesterase domain
(TE). This organization is consistent with a role in catalyzing the
last step of chain elongation and the subsequent release of
the PKS chain. However, the formation of an unsaturated six-
member lactone differs from many TE domains of Type I PKS
that have been studied to date. Similar cases have only been
demonstrated in phoslactomycin and leptomycin biosynthesis.
The product of the last module, which contains a cis-D2,3-double
bond, should consist of a keto reductase (KR) domain, followed
by a dehydration (DH) domain. However, the DH domain is not
found in the last module of fostriecin, phoslactomycin or lepto-
mycin (Figure 3). Although Module 1 has a solo enoyl reductase
(ER) domain, the conjugated triene property of fostriecin indi-
cates that this ER is inactive. Otherwise, there should be a satu-
rated bond between C16 and C17.
The fostriecin gene cluster also contains genes that encode
the set of tailoring enzymes FosM, FosH, FosJ, and FosK as
outlined in Figure 2. FosM (named ORF4 in previous research)
(Palaniappan et al., 2008), was deduced to be a homologous
NAD-dependent epimerase/dehydratase family protein with up
to 42% sequence similarity to the phoslactomycin gene plmT2,
which facilitates the formation of cis-D2,3-double bonds even
if the targeting compound M-PLMB could transfer double
bonds to PLM B without the function of PlmT2. FosH, which is
homologous to PlmT5 as a homoserine kinase family member,
is likely responsible for phosphorylation of the hydroxyl group
at the C-9 position. FosG, FosJ, and FosK share sequence
similarities to cytochromeP450 hydroxylase, andmay contribute
to the oxidation of C-4, C-8, and C-18. FosK is homologous
to the PlmS2 in phoslactomycin, which is involved in a cyclo-
hexyl-modifying hydroxylation at the C-18 position. There is no
hydroxylation at the C-8 in phoslactomycin biosynthesis. The
fostriecin gene cluster also contains other ORFs that remain to
be elucidated.
Gene Disruption of fosJ and Isolation of Intermediates
Analysis of the fostriecin biosynthetic gene cluster and the
chemical structure of fostriecin indicated that there are three
steps of hydroxylation (at C-4, C-8, and C-18) after the polyke-
tide chain is released that likely involve the fosK, fosJ, and
fosG genes, which encode proteins highly homologous to the
cytochrome P450 monooxygenases. To better understand fos-Chemistry & Biology 20,triecin biosynthesis and characterize the enzyme functions, the
fosJ gene was disrupted to block one of the hydroxylations in
the biosynthesis.
The loss of the fosJ gene was achieved through double cross-
over using REDIRECT technology (Gust et al., 2003). The target
gene, which was identified on the Cfos-F3 cosmid, was replaced
by the aac(3)IV/oriT (red) cassette using PCR targeting strate-
gies, yielding a mutated cosmid Cfos-F3-J. The mutated cosmid
was introduced into Escherichia coli ET12567/pUZ8002 by elec-
troporation and was subsequently transferred into the target
strain by conjugation (Kieser et al., 2000). The desired double
crossover mutants, which were selected by their apramycin-
resistant and kanamycin-sensitive phenotype, was isolated as
STQ0701 (DfosJ) (Figure S1A available online) and confirmed
by PCR analysis (Figure S1B).
Using the fermentation and isolationmethod, theDfosJmutant
strain was fermented and processed along with the wild-type
strain as a positive control. Following wild-type fermentation,
fostriecin is the predominant product, accompanied by themajor
analog PD113,271 and the minor analog PD113,270, as ex-
pected (Figure 4A). However, fostriecin, along with PD113,270
and PD113,271, were completely abolished in the DfosJmutant.
Instead, a series of analogues (1–5) were isolated from the DfosJ
mutant (STQ0701) (Figure 4A). The chemical structures of
compounds 1–5 were characterized by high-resolution mass
spectrometry (HR-MS) and nuclear magnetic resonance (NMR)
analysis (Figure 4B), with the exception that the 13C NMR
analysis of compound 5 was not completed due to its chemical
instability and the difficulty in isolating it (shown in Tables S3–S6)
(Boger et al., 1997; Stampwala et al., 1983). The structure details
are described in Text S1.
As shown in Figure 4B, all of the fostriecin intermediates (1–5)
that were isolated from STQ0701 lack the C-8 hydroxyl group,
indicating that FosJ may be responsible for C-8 hydroxylation.
Compounds 1, 2, 4, and 5 also lack hydroxyl groups at the C-4
and C-18 positions. Compound 3 has a hydroxyl group at both
C-4 and C-18, respectively, and also has a phosphoryl group
at C-9. This result suggests that FosJ must be active early in
the pathway with relaxed substrate specificity and can be by-
passed by enzymes for downstream modification steps during
fostriecin biosynthesis.
Complementation of the STQ0701 mutant with an expression
construct coding the fosJ gene on a pSET152 vector under
the ermE* promoter through recombinant conjugation resulted
in a complemented strain, STQ0702 (DfosJ + fosJ). The result-
ing strain has restored production of fostriecin, PD113,270,
and PD113,271 (Figure 4A) as in the wild-type, but it still accu-
mulated a small amount of compound 3. Compound 3, the45–54, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 47
Table 1. Deduced Functions of Open Reading Frames for Post-PKS in the Fostriecin Biosynthetic Gene Cluster
Gene Sizea Putative Function Closest Homolog Identity/Similarity
fosG 409 cytochrome P450 monooxygenase S. lavendulae ORF4 47/68
fosH 316 homoserine kinase S. HK803 PlmT5 44/62
fosI 424 ABC transporter S. HK803 PlmS4 51/66
fosJ 420 cytochrome P450 monooxygenase S. HK803 PlmT4 55/72
fosK 398 cytochrome P450 monooxygenase S. HK803 PlmS2 59/72
fosL 290 putative hydrolase S. HK803 PlmS3 50/66
fosM 313 NAD-dependent epimerase/dehydratase family protein S. HK803 PlmT2 42/56
orf1 284 methyltransferase S. violaceusniger Tu4113 71/80
orf2 165 MarR-family transcriptional regulator Catenulispora acidiphila DSM 44928 63/83
orf 3 213 metallo-b-lactamase superfamily protein S. hygroscopicus ATCC53653 50/63
orf 4 958 LuxR-family transcriptional regulator Saccharopolyspora erythraea NRRL 2338 32/44
orf 5 429 GH3-superfamily Planctomyces limnophilus DSM 3776 28/46
orf 6 722 3-hydroxy-3-methylglutaryl coenzyme A reductase Photorhabdus luminescens subsp. plu4507 38/57
orf 7 258 thioesterase S. avermitilis AveG 51/67
orf 8 633 heat shock protein S. coelicolor HtpG 80/89
aNumber of amino acids.
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post-PKS process persisted successfully in the absence of
FosJ. Fostriecin production in STQ0702 was confirmed by
coinjection with purified authentic standards and by mass
spectrometric analysis. The results of the complementation
experiment indicate that the five intermediates that were iso-
lated from the fosJ mutant, as in a different stage of biosyn-
thesis, are not the result of a polar effect of fosJ mutation.
The lack of the C-8 hydroxyl group may impact downstream
enzymes to some degree.
Gene Disruption of fosH and Isolation of Intermediate
Homology analysis showed that fosH shares 43% sequence
identity with plmT5,which was derived from the phoslactomycin
biosynthetic gene cluster. Therefore, we proposed that the
fosH gene, which is located downstream of the fosG gene in
the gene cluster, may be in charge of the phosphorylation of
C9-OH in fostriecin biosynthesis. To investigate this hypothesis,
a fosH deletion mutant was constructed using the REDIRECT
technology as above. The target gene, fosH, which was identi-
fied on the Cfos-F3 cosmid, was replaced by the aac(3)IV/oriT
(red) cassette using PCR targeting strategies and yielded
a mutated cosmid, Cfos-F3-H. The mutated cosmid was intro-
duced into E. coli ET12567/pUZ8002 by electroporation and
was subsequently transferred into a fostriecin producer by
conjugation (Kieser et al., 2000). The desired double crossover
mutants, selected by their apramycin-resistant and kanamycin-
sensitive phenotype, were isolated as STQ0703 (DfosH) (Fig-
ure S1A) and confirmed by PCR analysis (Figure S1C).
The DfosH mutant (STQ0703) was fermented and processed
along with the wild-type strain as previously described. The
production of fostriecin, along with PD113,270 and PD113,271,
were also completely abolished in the DfosH mutant. However,
an analogue (6), found in significant amounts, was isolated
from the DfosH mutant. When the fermentation period was
extended, aminor amount of compound (7) began to accumulate
(Figure 4A). The chemical structures of compounds 6 and 748 Chemistry & Biology 20, 45–54, January 24, 2013 ª2013 Elsevierwere characterized by HR-MS and NMR analysis as shown in
Figure 4B. Moreover, a 2D-NMR analysis of compound 6 was
measured to establish its absolute configuration completely
despite its chemical instability (Tables S3–S6). The structure
details are described in Text S1.
The DfosH mutant predominantly produces compound 6,
suggesting that the fosH gene plays an essential role in phos-
phorylation in fostriecin biosynthesis and that the occurrence
of C-9 phosphorylation has an obvious impact on the down-
stream tailoring enzymes. However, fosH lies downstream of
fosG and upstream of fosJ in the gene cluster. The fosK gene
lies in the opposite transcriptional direction near fosJ, as shown
in Figure 2. Considering the existence of the C-8 hydroxyl group
in compound 6, FosH inactivation should not have a polar effect
on its downstream enzymes.
Characterization of theHomoserineKinase FosH In Vitro
by Heterologous Expression in E. coli
To further investigate the function of FosH in the biosynthesis
pathway, an enzyme activity assay was performed in vitro. A
FosH heterologous expression system was constructed on
pET28b and introduced into E. coli BL21 to produce the target
protein. The expression construct was confirmed by DNA
sequencing and the target protein (labeled as EH1) was purified
as described in the Experimental Procedures and analyzed
by SDS-PAGE analysis (Sambrook et al., 1989) (Figures S2
and S3).
As shown in Figure 5, compounds 1 and PD114,631 (Hokan-
son and French, 1985) could be converted to compounds 2
and fostriecin, respectively, by EH1 in vitro. This result supports
the hypothesis that FosH is responsible for the phosphorylation
of fostriecin and that its function can be processed whether
hydroxylation at C-8 and C-18 occurred or not. Meanwhile,
compound 1 can also be phosphorylated by EH1 to yield
compound 2 up to 95% of the time under adequate reaction
conditions. Combined with the isolation of compound 5 in
DfosJ mutants, FosH could convert PD114,631, compound 1Ltd All rights reserved
Figure 3. Proposed Fostriecin Polyketide Domain Organization and Biosynthetic Pathway in Streptomyces pulveraceus
Fostriecin polyketide biosynthesis uses a conventional PKS biosynthesis rule except that the ER domain inModule 1 is inactive. ACP, acyl carrier protein; AT, acyl
transferase; DH, dehydratase; ER, enoyl reductase; KR, ketoreductase; KS, ketosynthase; TE, thioesterase.
Chemistry & Biology
Fostriecin Biosynthesis Mechanismand compound 4 into fostriecin, compound 2 and compound 5
in vitro or in vivo, indicating that FosH has a relaxed substrate
specificity.
DISCUSSION
Fostriecin Biosynthesis Gene Cluster from
Streptomyces pulveraceus
Inspired by the unusual biological activity and specific chemical
structure (the cis-D2,3-double bond, phosphate ester, and con-
jugated triene), we developed a cloning strategy to isolate the
fostriecin gene cluster for elucidating its biosynthesis mecha-
nism. As summarized in Table 1, the fos gene cluster was found
to consist of 21 ORFs encoding six modular Type I polyketide
synthases (FosA-F) and seven tailoring enzymes, including three
cytochrome P450 (FosG, FosJ, and FosK), one homoserine
kinase (FosH), one transport protein (FosI), one putative hydro-Chemistry & Biology 20,lase (FosL), and one NAD-dependent epimerase/dehydratase
family protein (FosM). The fos gene cluster boundaries were
precisely determined based on sequencing of the entire fos
gene cluster. Different ORFs with varying functions may repre-
sent a possible fostriecin biosynthesis mechanism that has not
been previously reported. This work provides a molecular basis
for understanding the complex fostriecin biosynthetic mecha-
nism and for generating various fostriecin analogs via combina-
torial biosynthesis.
Functional Analysis of the Tailoring Enzymes FosJ
and FosH in the Biosynthesis of Fostriecin
Inactivation of one of the tailoring enzymes, FosJ, not only results
in the abolishment of the biosynthesis of fostriecin along with its
natural analogs PD113,721 and PD113,720 but also allows the
accumulation of five intermediates in the DfosJ mutant. All five
intermediates lack a C-8 hydroxyl group. When theDfosJmutant45–54, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 49
Figure 4. Disruption of the fosJ and fosHGenes and the Structure of
Isolated Intermediates
(A) HPLC chromatograms of culture extract for DfosJ and DfosH gene
disruption mutants, DfosJ complementation mutant, and wild-type strain. The
mutant constructs are described in Figure S1 and Tables S1 and S2.
(B) The chemical structure of compounds 1–7 from DfosJ and DfosH mutant
strains. NMR data are listed in Tables S3–S6, and the detailed structure
elucidations are described in Text S1.
Figure 5. In Vitro Enzyme Activity Assay of Purified FosH Protein:
EH1
(A) Four standard compounds in a coinjection.
(B) EH1 enzyme catalyzing reaction analysis of compound 1.
(C) The control substrate reaction analysis of compound 1without EH1 protein.
(D) EH1 enzyme catalyzing reaction analysis of PD114,631.
(E) The control substrate reaction analysis of PD114,631 without EH1 protein.
The construct and confirmation of FosH heterologous expression system are
shown in Figures S2 and S3.
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mutant strain (DfosJ + fosJ), the fostriecin production was
restored. Together, these results confirmed that fosJ is respon-
sible for C-8 oxidation in fostriecin biosynthesis. However,
compound 3 still contains two hydroxyl groups at C-4 and
C-18 and a phosphoryl group. This suggests that the loss of
the C-8 hydroxyl group has little impact on the downstream
post-PKS modification process.
FosH was demonstrated to be responsible for C-9 phospho-
rylation of fostriecin based on gene inactivation and an in vitro
enzyme activity assay. The genetic loss of fosH in the wild-
type producer completely blocked fostriecin production, but
compound 6 accumulated as the major intermediate, indicating
that FosJ is functions to perform hydroxylation at the C-8 in the
DfosH mutant, suggesting that there is not a polar effect in the
fosH disruption mutant. In other words, lack of phosphorylation
at the C-9 could have a significant impact on the activities of50 Chemistry & Biology 20, 45–54, January 24, 2013 ª2013 Elsevierdownstream enzymes, but FosH-mediated phosphorylation
in vitro may have relaxed specificity.
cis-D2,3-Double Bond Formation in Fostriecin Is from
Malonylated Intermediates
The isolation and characterization of three malonylated
compounds (4, 5, and 6) fromDfosJ andDfosHmutants provides
a further insight for cis-D2,3-double bond formation in fostriecin
biosynthesis. General PKS chain elongation is terminated or
cycled to form a lactone ring that is liberated by the TE enzyme
and followed by a series of post-PKS modification steps in
common polyketide biosynthesis. Because the predicted
dehydratase (DH) domain in the last module is absent in fostrie-
cin, phoslactomycin, and leptomycin, the polyketide chain of
the six-membered lactone should contain a hydroxyl group at
the C-3 site (Khosla et al., 1999). However, unexpectedly, the
cis-D2,3-double bond in the unsaturated six-member lactone
moiety is formed in fostriecin, phoslactomycin, and leptomycin
biosynthesis, and several of the malonylated compounds
are found in the fostriecin mutants (DfosJ, DfosH) and the
phoslactomycin mutant (DplmT2), in which the C-3 hydroxyl
group is esterified with malonic acid to create malonylated
compounds (Palaniappan et al., 2008). The function of PlmT2
or FosM (named ORF4 in the phoslactomycin report) has been
proposed following plasmid-based expression of plmT2 or
fosM that facilitates the eventual formation of the unsaturated
lactone. Our data support the idea that similar dehydratase-
independent pathways, which process the malonylation andLtd All rights reserved
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possibly leptomycin formation, as well as in phoslactomycin
biosynthesis, to generate the cis-D2,3-double bonds in the
six-membered lactone moieties. To this point, isolation of malo-
nylated compound 4 from the DfosJ mutant suggests that the
malonylation process occurred at an early stage, most likely
preceding the release of the full length polyketide intermediate
from Fos-PKS (Figure 3).
Post-PKS Modification Pathway in Fostriecin
Biosynthesis
Structurally, the natural fostriecin has four varying functional-
ities that are absent from the molecule generated from PKS,
including two hydroxyl groups at the C-8 and C-18 positions,
a phosphoryl group at the C-9 position and an unsaturated
double bond at the C2-C3 site. After PKS elongation and liber-
ation from PKS by the TE enzyme, the nascent PKS chain
undergoes some or all of the normal postmodification steps
that are typically associated with fostriecin natural product
biosynthesis, such as hydroxylation, phosphorylation, and
others.
A biosynthesis pathway featuring specific chemistry for
unsaturated six-membered lactone has been proposed based
on our findings in this study from the sequencing of the fos
gene cluster, the deduced function of the ORFs within the fos
gene cluster and the in vivo/in vitro analysis of selected genes
by targeted gene inactivation, mutant complementation, and
enzyme activity assays. This proposal is also based on the
structural characterization of the isolated intermediates.
The isolation of compound 4 from the fosJ deletion mutant
indicates that malonic acid is linked to the PKS chain at module
eight during PKS elongation; most likely, it precedes the release
of the full length polyketide intermediate from Fos-PKS. A series
of malonylated compounds from the DfosJ and DfosH mutants
also suggest that malonylation is an efficient process and
occurs in the early stage, following the post-PKS modification
steps in fostriecin biosynthesis and providing the primary basis
for following the post-PKS modification pathway in fostriecin
biosynthesis.
A rational post-PKS processing pathway is proposed. The
malonylated compound 4, liberated from PKS elongation by
TE, was catalyzed by FosJ to form compound 6. Then, fosH
could catalyze the phosphorylation of compound 6 to create
the potentially malonylated compound 8. Compounds 8 and 9
were isolated from FosK and FosM mutants to support this
proposal (unpublished data). The oxidation of C-18 by FosK
may proceed before C-4 oxidation by FosG. We believe that
C-4 oxidation must follow the unsaturated 6-membered lactone
ring formation. Therefore, cis-D2,3-double bond formation should
be the last step in post-PKS tailoring of fostriecin biosynthesis
to yield fostriecin (Figure 6). Finally, FosG modification occurs
on fostriecin to produce PD 113,271.
It is worth mentioning that FosJ could be bypassed in the
DfosJ mutants, leading to the accumulation of compound 3.
The small amount of nonmalonylated compounds 1 and 2 that
were isolated from the DfosJ mutant, and compound 7 from
the DfosH mutant and PD113270 from the wild-type could be
derived from the unstable decomposition of compounds 4, 5,
6, and 8, respectively.Chemistry & Biology 20,SIGNIFICANCE
Fostriecin is a natural phosphate ester product with potent
antitumor activity. The fostriecin biosynthetic gene cluster
described here provides the molecular basis for under-
standing the complex fostriecin biosynthetic mechanism.
Gene disruption of fosJ or fosH and an in vitro enzyme
activity assay of heterologously expressed FosH establish
that FosJ mediates oxidation at the C-8 position, whereas
FosH drives phosphorylation at the C-9 position. The inter-
mediates isolated from the mutants indicate that malony-
lated polyketide formation could be a normal biosynthetic
process in the eventual formation of unsaturated six-
membered lactones. The proposed pathway for fostriecin
post-PKS modification sets the stage for understanding
the mechanisms that build these structurally unique and
pharmaceutically important agents and contributes to the
general field of combinatorial biosynthesis.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Reagents
E. coli DH5a was used as the host for standard cloning experiments. E. coli
ET12567/pUZ8002 was used as cosmid donor host for E. coli-Streptomyces
conjugation. E. coli BW25113/pIJ773 was provided by John Innes Center
(Norwich, UK) as part of the REDIRECT Technology kit. SuperCos1 (Strata-
gene) and E. coli DH5a were used to construct the S. pulveraceus genomic
library. The Streptomyces pulveraceus ATCC 31906 was purchased from
ATCC. E. coli BL21(DE3) and pET28b(+) (Novagen) was used for heterologous
expression of fosH gene.
All reagents including biochemicals, chemicals, media, restriction enzymes,
and other molecular biological reagents were acquired from standard
commercial sources. All growth media for Streptomyces and E. coli were
prepared according to standard protocol.
DNA Isolation and Manipulation
DNA isolation and manipulation in E. coli and Streptomyces were carried
out according to standard methods (Kieser, et al., 2000). PCR amplifications
were carried out on a PCR machine (Bio-Rad) using Taq DNA polymerase.
Primer synthesis and DNA sequencing were performed at TaKaRa (Dalian).
Construction of Genomic Library and Screening
Streptomyces sp. ATCC 31906 genomic DNA was partially digested with
Sau3AI to yield a smear of 30–40 kb, dephosphorylated with shrimp alkaline
phosphatase, and ligated into SuperCos1, where it was pretreated with XbaI,
dephosphorylated, and then digested with BamHI. The resulting ligation
mixture was packaged using the Gigapack XIII (Stratagene) and transduced
into E. coli DH5a to generate the genomic library. The transduced cells were
spread onto LB plates containing ampicillin, and the plates were incubated
at 37C overnight.
Approximately 1,000 cosmids from the E. coli transductants were harvested
from the above ligation mixture and were sequenced with two reactions
using convergent primers T7cos (50-CATAATACGACTCACTATAGGG)
and T3cos-1 (50-TTCCCCGAAAAGTGCCAC). After BLAST analysis, the
sequences revealed 28 cosmids carrying DNA fragments that encoded
Type I or Type II PKS genes at either end or both ends. Based on the relation-
ships among these cosmids, four cosmids (Cfos-F1, Cfos-F2, Cfos-F3, and
Cfos-F4), were selected to be investigated further for the fostriecin gene
cluster.
DNA Sequencing and Analysis
The 73 kb regions from the four cosmids were sequenced using Big Dye
Terminator chemistry (Applied Biosystems). The DNA was assembled with
Sequencher 4.1 (Gene Codes), and the corresponding deduced protein
sequences were analyzed with Mac Vector 6.5.3 (Accelrys) software and45–54, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 51
Figure 6. A Proposed Post-PKS Modification Pathway in the Biosynthesis of Fostriecin
The main post-PKS biosynthesis pathway is depicted in the box indicating by a solid arrow, then a shunt pathway occurs in the fosJ deletion mutant to
produce compound 3, as indicated with a simple arrow. Compounds 1, 2, and 7 and PD113,270 are derived from the decomposition of compounds 4, 5, 6, and
potentially compound 8, respectively, as depicted with a dashed arrow. The isolation of compounds 8 and 9 was completed in the DfosK and DfosM mutants,
respectively.
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BLAST programs available through the National Center for Biotechnology
Information.
Gene Disruption of fosJ or fosH and fosJ Gene Complementation
The fosJ and fosH geneswere disrupted using REDIRECT Technology accord-
ing to the literature protocol (Gust et al., 2003). All primers for genetic manip-
ulation were listed in Tables S1 and S2. Briefly, the apramycin gene aac(3)IV/
oriT (red) cassette was used to replace an internal region of the target gene
fosJ and fosH. The mutant cosmids Cfos-F3-J (DfosJ) and Cfos-F3-H (DfosH)
were constructed and then introduced into Streptomyces pulveraceus by
conjugation from E. coli ET12567/pUZ8002 according to the literature pro-
cedure. Streptomyces spores were suspended in 23 YT medium and heat
shocked for 10 min at 50C. Germinated spores were mixed with E. coli
ET12567/pUZ8002 harboring pSET152 with different donor/recipient ratios
from 1:1 to 10:1 and spread onto freshly modified MS plates. The plates
were incubated at 30C for 16–18 hr and then overlaid with 1 ml of water
containing apramycin and nalidixic acid at respective final concentrations of52 Chemistry & Biology 20, 45–54, January 24, 2013 ª2013 Elsevier25 mg/ml. The plates were incubated further at 30C for 72 hr, and the excon-
jugants appeared. The desired double crossover mutants, selected by their
apramycin-resistant and kanamycin-sensitive phenotype, were isolated as
STQ0701 (DfosJ) and STQ0703 (DfosH). The genotypes were confirmed by
PCR analysis (Figure S1).
To construct expression plasmids for the genetic complementation experi-
ment, the fosJ gene was amplified with the forward primer: 50-GGACTAGTAT
GACCTCGACCGACGCCGT-30, and the reverse primer: 50-CGGAATTCTCAC
CAGGTGACGGGCAG-30. The products were digested by SpeI and EcoRI
and cloned into pSET152 to generate pSET152-J. It was introduced into the
fosJ mutant strain STQ0701 by conjugation to yield the complemented
strain STQ0702 in which the DfosJ mutation was complemented by the con-
stitutive expression of functional copies of fosJ under the control of the
ermE* promoter.
Heterologous Expression and FosH In Vitro Activity Assay
A 1,084 bpDNA fragment was amplified fromCfos-F3with 50-AACATATGCCG
GAATCGACCGACG-30 and 50-CGGAATTCTCAGAAAACCTGGAAACGGG-30Ltd All rights reserved
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DH5a to generate pET28b-EH1 vectors. The resulting plasmid was confirmed
by electrophoresis analysis as reported in Figure S3. It was then transformed
into E. coli BL21 (DE3), yielding the BL21-EH1 strain. The overproduction and
purification of EH1 were performed using the following protocol. The E. coli
strain BL21-EH1 was cultivated with shaking at 28C in LBmedium containing
50mg/ml kanamycin and induced with 0.5mM IPTG (isopropyl-b-D-thiogalac-
topyranoside) when the culture reached an OD600 of 0.5. After induction, incu-
bation was continued for 5 hr. The cells were then harvested by centrifugation
and suspended in 0.1 M PBS buffer. After suspension, the cells were lysed by
lysozyme with a terminal concentration of 1 mg/ml and ultrasonic disruption.
Cellular debris was removed from the lysate by centrifugation, and the protein
was obtained. The EH1-His-tag protein was purified by affinity chromatog-
raphy using Ni-NTA Superflow resin (GE). Fractions containing the desired
protein were pooled and dialyzed using a Centrifugal Filter Device. All of the
protein purification procedures were carried out at 4C. The final cell pellet
and the soluble and insoluble fractions were analyzed via SDS-PAGE to
confirm the presence of the proteins as reported in Figure S4. The activity
of EH1 was assayed in a mixture containing 0.5 mM dephosphated
fostriecin analogs, 1 mM ATP, 5 mM MgCl2, and FosH protein (EH1) in
75 mM Tris-HCl, pH 8.3. The catalysis process was sustained for 24 hr
and monitored at different time points by high-performance liquid chromatog-
raphy (HPLC).
In this study, compound 1 and dephosphoryl-fostriecin (PD114, 631) were
used to determine FosH function. PD114,631 is prepared by the chemical
method of dephosphorylating fostriecin according to a previously reported
method (Hokanson and French, 1985).
Production, Purification, and Analysis of Fostriecin and Its
Analogues from Wild-type and Mutant Strains
The S. pulveraceus of wild-type strain, DfosJ mutant strain (STQ0701), DfosJ
mutant complementation strain (STQ0702, DfosJ + fosJ), and DfosH mutant
strain (STQ0703) were fermented under the following conditions. The spore
suspension was first inoculated into 30 ml of YPD medium in a 250 ml flask
and incubated at 28C and 220 rpm for 24 hr. The resulting seed culture
was inoculated into fermentation medium (consists of 5% glycerol, 0.4%
baker’s yeast, 0.5% meat extract, 0.1% NaCl, 0.25% CaCO3, 0.25%
K2HPO4, pH 7.0) incubated at 28
C and 220 rpm for another 4 days for produc-
tion. The fermentation broth was then centrifuged to remove the mycelia and
the supernatant was loaded on the HP20SS equilibrated with 0.05 M phos-
phate buffer (pH 6.8), then the column was eluted with methanol, the fractions
containing fostriecin or its analogs were collected, and evaporated to generate
an oily residue. The oily residue was dissolved in CH3OH and diluted to 10%
methanol concentration with 0.1 M phosphate buffer (pH 6.8), then loaded
on C18 chromatography with the methanol-buffer as mobile phase. A stepped
gradient elution of methanol-buffer (10%, 20%, 30%, 40%, 50%, 60% meth-
anol in buffer) was used to elute the column. All fractions containing fostriecin
or its analogs were collected and concentrated in vacuum to produce an
oily residue individually.
For compound purification, the samples were subjected to final purification
by semipreparative chromatography (ZORBAX SB-C1 8,250 mm 3 9.4 mm,
5 mm) to give pure objective compounds as follows: fostriecin, PD113,271,
and PD 113,270 were from wild-type fermentation; compounds 1–5 from
STQ0701, and compounds 6 and 7 from STQ0703.
All samples were subjected to HPLC analysis with a DAD detector (Agilent
1200). A gradient elution from 10% to 60% methanol over 25 min, followed a
gradient from 60% to 90% methanol in 5 min was developed with 1 ml/min
elution speed at 267 nm wavelength.
Structure Determination
The UV spectrums of the purified analogs were determined in an acetonitrile
solution with DAD detector by Agilent 1200 HPLC. For NMR analysis,
compounds were dried and dissolved in CD3OD.
1H and 13C NMR spectra
were recorded on a Bruker Avance II400 spectrometer operating at
400 MHz and 100.61 MHz, respectively. The molecular mass was determined
with Q-TOF-HRMS or API-ES-MS spectrometer (HP1100MSD).
The 1H and 13C NMR assignments of 1–7 were listed in Tables S3–S6, the
detailed structure elucidation is provided in Text S1.Chemistry & Biology 20,ACCESSION NUMBERS
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